BIA makes appointments
This article was originally published in Scrip
TheBIA, the UK's Bioindustry Association, has confirmed Dr Clive Dix as chairman of the board of directors. Dr Dix serves as non-executive chairman of Modern Biosciences and has more than 15 years experience serving in senior positions within the pharmaceutical industry. The association also elected Allan Marchington, a partner at Apposite Capital, a new member of its board of directors and reappointed Glyn Edwards, CEO ofAntisoma.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
The R&D-based lobby group, Medicines Australia, has published a report calling for stakeholders across the Australian healthcare ecosystem to discuss how to “pragmatically address the evidence needs of the future.”
NICE will review new data in deciding whether to ok the use of Spinraza in non-ambulant SMA type III patients.